Deadline in Lawsuit for Investors in Arconic Inc. (ARNC-PB)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
20
Deadline in Lawsuit for Investors in Arconic Inc. (ARNC-PB) Depositary Shares announced by Shareholders Foundation

SAN DIEGO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc.  ( mail@shareholdersfoundation.com ) announces that a deadline is coming up on December 8, 2017 in the lawsuit that was filed for investors who purchased Arconic Inc. (ARNC-PB) Depositary Shares, each representing a 1/10th interest in a share of 5.375% Class B Mandatory Convertible Preferred Stock, Series 1, par value $1 per share, liquidation preference $500 per share pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with Arconic’s September 18, 2014 initial public stock offering (“IPO”).

Investors who purchased Arconic. (ARNC-PB) Depositary Shares, each representing a 1/10th interest in a share of 5.375% Class B Mandatory Convertible  Preferred Stock, Series 1, par value $1 per share, liquidation preference $500 per share should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that Arconic, certain of its current and former officers and/or directors and certain underwriters violated the Securities Act of 1933. On or about July 11, 2014, Arconic filed with the SEC a Registration Statement on Form S-3, which would later be utilized for Arconic’s September 18, 2014 IPO.

The plaintiff claims that the Registration Statement for Arconic’s September 18, 2014 IPO was allegedly negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and was not prepared in accordance with the rules and regulations governing its preparation.

More specifically, the plaintiff alleges that at the time of Arconic’s September 18, 2014 IPO, Arconic had been knowingly selling its Reynobond PE panels for use on high-rise residential towers in the United Kingdom and other countries and allegedly knew that the product was being used in an inappropriate manner that could expose the Company to significant civil, regulatory and/or criminal liability. The plaintiff said that the uncertainty associated with these sales practices was reasonably likely to have a material impact on Arconic’s profitability, and, therefore, was required to be disclosed in the Registration Statement for Arconic’s September 18, 2014 IPO but was not.

Those who purchased Arconic. (ARNC-PB) Depositary Shares, each representing a 1/10th interest in a share of 5.375% Class B Mandatory Convertible Preferred Stock, Series 1, par value $1 per share, liquidation preference $500 per share should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.   CONTACT: Shareholders Foundation, Inc.  Michael Daniels  +1 (858) 779-1554  mail@shareholdersfoundation.com  3111 Camino Del Rio North  Suite 423  San Diego, CA 92108

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Topicus.com Inc. Reports Impressive Q3 Growth in Earnings

Updated Category News Views 392

Topicus.com Inc. Achieves Record Financial Results in Q3 2024 Today, Topicus.com Inc. (TSXV: TOI) has shared promising financial data for the third quarter of 2024, indicating a strong upward trajectory in both revenue and profits. This positive news reflects a robust business performance managed under the guidance of Constellation Software Inc. (TSX: CSU). All figures...

Continue Reading
Rumble Experiences Significant Stock Surge with Dr Disrespect Deal

Updated Category News Views 97

Rumble Stock Experiences Notable Increase Rumble has recently witnessed a remarkable surge in its shares, jumping by as much as 17%. This increase represents the most significant intraday rise seen since July, attributed to an exciting partnership with gaming sensation Dr Disrespect. Exclusive Streaming Agreement with Dr Disrespect Under the partnership, Dr Disrespect...

Continue Reading
Michelin's Recent Trading Insights and Share Buyback Strategy

Updated Category News Views 227

Understanding Michelin's Share Buyback Initiative Michelin, well-known for its premium tire products, has been actively engaging in share repurchase activities. This initiative is significant for any investor as it showcases the company's robust financial health and strategic approach to increasing shareholder value. By buying back its shares, Michelin signals confidence...

Continue Reading
Treasury Yields Remain Steady as Inflation Data Looms

Updated Category Economy Views 300

Treasury Yields Steady Ahead of Key Inflation Data Treasury rates are not changing much while the market waits for important inflation figures. Investor caution is high in the last week of June. They are delaying significant actions until the report on Friday. Slightly higher is the yield on the 10-year Treasury. Similar little gains are seen in the two-year yield. The...

Continue Reading
MDPI Set to Transform Peer Review with Innovative Technology

Updated Category News Views 146

MDPI's Innovations in Peer Review MDPI, a leading open access (OA) publisher, is transforming the peer review process with new technology. This initiative ties in seamlessly with the upcoming Peer Review Week 2024, which focuses on 'Innovation and Technology in Peer Review'. Set to take place at the end of September, this event aims to showcase the evolving world of...

Continue Reading